This year, the New York City-based Cancer Research Institute (CRI) honored three prominent scientists with its William B. Coley Awards for Distinguished Research, which recognize outstanding research ...

Michel Goldman, 67, a top European immunologist and vaccine expert, believes a COVID-19 booster shot accelerated the growth of his cancer. In a report published on Saturday, speaking in long detail ...

The National Cancer Institute has awarded $328,000 to Dartmouth's Norris Cotton Cancer Center; cancer immunology research scientists who study antibodies will investigate how antibody responses affect ...

A bone marrow transplant can buy time for people with aggressive B-cell cancers. Too often, it does not buy enough. For ...

Our immune system is great at protecting us from infections and cancer. Except when it doesn’t. For reasons that are not entirely clear, the T cells that normally mount an effective response against ...

Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a ...

Cancer immunotherapy drugs trigger the body's immune system to attack tumors and have revolutionized the treatment of certain cancers, such as lymphoma, lung cancer and melanoma. Yet, while some ...

Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into a suppressed state. This previously unrecognized molecular interaction, ...

Cancer immunologists here have discovered how a protein on the surface of antibody-making immune cells boosts the amount of antibody the cells make. The protein, called CD86, is present on B ...

Eugene Overton was given two options after being diagnosed with melanoma last year: standard chemotherapy or an experimental treatment. Overton chose the experiment, an injection he receives every ...

A new study indicates a way for cancer immunotherapy to spur a more robust immune response. Such knowledge could lead to the development of better cancer vaccines and more effective immunotherapy ...